IP Library Granted Patent US 8,145,435
Granted Patent B2
US 8,145,435 · App. 12/789,101 · Granted Mar 27, 2012

Real-time amplification and monitoring system incorporating vector-based algorithm for analyzing polynucleotide-containing samples

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,145,435
App. No.
12/789,101
Granted
Mar 27, 2012
Kind
B2
Abstract

System for analyzing a polynucleotide-containing sample using real-time amplification and monitoring. The system includes a computer or processing device with software for performing a vector analysis of growth curves. The vector analysis advantageously simplifies polynucleotide quantitation by circumventing the need to establish thresholds used for calculating initiation of the growth phase, or to calculate derivatives.

Claims (24)

1. A system for analyzing a polynucleotide-containing sample by time-dependent monitoring of an in vitro nucleic acid amplification reaction, said system comprising:

an apparatus comprising a temperature-controlled incubator and a fluorescence monitoring device, said apparatus generating a data set comprising values proportional to the amount of analyte amplicon present in the in vitro nucleic acid amplification reaction as a function of time, said data set defining a growth curve;

a processing device that analyzes the data set defining the growth curve, said processing device comprising software instructions to perform a vector analysis of at least a portion of said growth curve to identify a time-dependent feature indicating a transition from the baseline phase into the growth phase of said growth curve, said vector analysis comprising the steps of,

(a) establishing a plurality of pairs of first and second vectors at different points on a time dimension of the growth curve,

wherein each vector of a single pair of vectors among said plurality has the same origin, and

wherein the head of the first vector and the head of the second vector of said single pair of vectors among said plurality are each positioned at different points on the growth curve,

(b) calculating for each pair of vectors the value of an angle therebetween, thereby resulting in a plurality of calculated angles, with each point on the time dimension of the growth curve being associated with a different one of said plurality of calculated angles,

(c) comparing the plurality of calculated angles with each other to identify a characteristic angle, and

(d) identifying said time-dependent feature of said growth curve as the point on the time dimension of the growth curve that is associated with the characteristic angle, said characteristic angle being either the maximum angle among the plurality of calculated angles or the minimum angle among the plurality of calculated angles; and

an output device in communication with the processing device.

2. The system of claim 1 , wherein the fluorescence monitoring device comprises a multiplexed fluorimeter.

3. The system of claim 1 , wherein the temperature-controlled incubator is a thermal cycling incubator.

4. The system of claim 1 , wherein said temperature-controlled incubator maintains constant temperature during the in vitro nucleic acid amplification reaction, said in vitro nucleic acid amplification reaction being an isothermal in vitro nucleic acid amplification reaction.

5. The system of claim 1 , wherein the temperature-controlled incubator is configured to hold a multiwell plate.

6. The system of claim 1 , wherein said processing device is an integral component of said apparatus.

7. The system of claim 1 , wherein said processing device is selected from the group consisting of a computer linked to said apparatus, and a computer that is an integral part of said apparatus.

8. The system of claim 7 , wherein the temperature-controlled incubator of said apparatus is a thermal cycling incubator.

9. The system of claim 1 , wherein said output device comprises a video monitor.

10. The system of claim 1 , wherein said processing device further comprises software instructions that direct said output device to display a quantitative value selected from the group consisting of a TArc value, an O-TArc value, a concentration of analyte polynucleotide, and an amount of analyte polynucleotide.

11. The system of claim 1 , wherein said processing device further comprises software instructions to perform the step of,

creating a calibration curve that correlates the time-dependent feature identified in step (d) and a starting amount of analyte polynucleotide present in the polynucleotide-containing sample.

12. The system of claim 1 , wherein said processing device further comprises software instructions to perform the steps of:

comparing the time-dependent feature identified in step (d) with a standard calibration curve; and

determining from said time-dependent feature of said growth curve and said standard calibration curve the amount of analyte polynucleotide present in the polynucleotide-containing sample.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →